Massonnet, P., Farre Segura, J., Cobraiville, G., Fillet, M., Servais, A.-C., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Le Goff, C., Bouquegneau, A., Jean-Claude Souberbielle, Vincent Delatour, Delanaye, P., & Cavalier, E. (09 April 2024). Quantification of 1-84 Parathyroid Hormone: from immunoassays to LC-MS/MS candidate reference measurement [Paper presentation]. Analytica 2024, Munich, Germany. Peer reviewed |
Pittie, G., LUKAS, P., MASSART, M., Cavalier, E., & Le Goff, C. (2023). Evaluation of analytical and clinical performance of the AFIAS Tn-I plus assay -a new point-of-care. Acta Cardiologica, 1-7. doi:10.1080/00015385.2023.2286423 Peer Reviewed verified by ORBi |
Cavalier, E., Farre Segura, J., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Massonnet, P., Le Goff, C., Bouquegneau, A., Souberbielle, J.-C., Delatour, V., & Delanaye, P. (2023). Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney International. doi:10.1016/j.kint.2023.09.033 Peer Reviewed verified by ORBi |
Farre Segura, J., Le Goff, C., LUKAS, P., Cobraiville, G., Fillet, M., Servais, A.-C., Delanaye, P., & Cavalier, E. (03 November 2022). Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure. Clinical Chemistry, 68 (11), 1399-1409. doi:10.1093/clinchem/hvac135 Peer Reviewed verified by ORBi |
Castiglione, V., Berodes, M., LUKAS, P., Louis, E., Cavalier, E., & Lutteri, L. (27 September 2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12 (10), 2338. doi:10.3390/diagnostics12102338 Peer reviewed |
Farre Segura, J., COBRAIVILLE, G., LUKAS, P., LE GOFF, C., Servais, A.-C., Fillet, M., DELANAYE, P., & CAVALIER, E. (11 April 2022). Development and validation of a candidate reference method for 1-84 PTH by LC-MS/MS [Poster presentation]. EuroMedLab 2021 Munich, Munich, Germany. |
Sempos, C. T., Williams, E. L., Carter, G. D., Jones, J., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Duewer, D. L., Kuszak, A. J., Merkel, J., Hoofnagle, A. N., LUKAS, P., Cavalier, E., Durazo-Arvizu, R. A., Crump, P. M., Popp, C., Beckert, C., Schultess, J., ... Wise, S. A. (2022). Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03742-5 Peer Reviewed verified by ORBi |
Cavalier, E., LUKAS, P., & DELANAYE, P. (2022). Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations. Clinical Chemistry and Laboratory Medicine, 60 (3), 394-400. doi:10.1515/cclm-2021-1190 Peer Reviewed verified by ORBi |
Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Hoofnagle, A. N., Ivison, F., Fischer, R., van den Ouweland, J. M. W., Ho, C. S., Law, E. W. K., Simard, J.-N., Gonthier, R., Holmquist, B., Meadows, S., ... Sempos, C. T. (January 2022). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D(3) on assay performance. Analytical and Bioanalytical Chemistry, 414 (1), 333-349. doi:10.1007/s00216-021-03576-1 Peer Reviewed verified by ORBi |
CASTIGLIONE, V., CAVALIER, E., LUTTERI, L., LUKAS, P., & BERODES, M. (19 November 2021). NEW FAECAL CALPROTECTIN ASSAY BY IDS: VALIDATION AND COMPARISON TO DIASORIN METHOD [Paper presentation]. RBSLM Annual Meeting, Brussels, Belgium. Editorial reviewed |
Wise, S. A., Camara, J. E., Sempos, C. T., LUKAS, P., Le Goff, C., PEETERS, S., Burdette, C. Q., Nalin, F., Hahm, G., Durazo-Arvizu, R. A., Kuszak, A. J., Merkel, J., & Cavalier, E. (September 2021). Vitamin D Standardization Program (VDSP) Intralaboratory Study for the Assessment of 25-Hydroxyvitamin D Assay Variability and Bias. Journal of Steroid Biochemistry and Molecular Biology, 212, 105917. doi:10.1016/j.jsbmb.2021.105917 Peer Reviewed verified by ORBi |
Camara, J. E., Wise, S. A., Hoofnagle, A. N., Williams, E. L., Carter, G. D., Jones, J., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., LUKAS, P., Cavalier, E., Popp, C., Beckert, C., Schultess, J., Van Slooten, G., Tourneur, C., ... Sempos, C. T. (August 2021). Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2. Analytical and Bioanalytical Chemistry, 413 (20), 5067-5084. doi:10.1007/s00216-021-03470-w Peer Reviewed verified by ORBi |
Cavalier, E., Fraser, C. G., Bhattoa, H. P., Heijboer, A. C., Makris, K., Ulmer, C. Z., Vesper, H. W., Vasikaran, S., LUKAS, P., DELANAYE, P., Carobene, A., & On Behalf Of The Ifcc-Iof Committee For Bone Metabolism. (January 2021). Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations. Nutrients, 13 (2). doi:10.3390/nu13020431 Peer Reviewed verified by ORBi |
Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Popp, C., Beckert, C., Schultess, J., Van Slooten, G., Tourneur, C., Pease, C., Kaul, R., Villarreal, A., Batista, M. C., Pham, H., ... Sempos, C. T. (2021). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 2 ligand binding assays - impact of 25-hydroxyvitamin D(2) and 24R,25-dihydroxyvitamin D(3) on assay performance. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03577-0 Peer Reviewed verified by ORBi |
Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients [Poster presentation]. 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting. |
Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients [Paper presentation]. 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting. |
CAVALIER, E., LUKAS, P., Warling, X., Moonen, M., Smelten, N., & DELANAYE, P. (2020). The percentage of non-oxidized PTH concentration remains stable over a period of 1 year in hemodialyzed patients. Clinica Chimica Acta, 506, 107-109. doi:10.1016/j.cca.2020.03.025 Peer Reviewed verified by ORBi |
Cavalier, E., LUKAS, P., Bottani, M., Aarsand, A. K., Ceriotti, F., Coşkun, A., Díaz-Garzón, J., Fernàndez-Calle, P., Guerra, E., Locatelli, M., Sandberg, S., Carobene, A., Åkesson, K., Bhattoa, H. P., Bruyère, O., Cooper, C., Eastell, R., Garnero, P., Heijboer, A., ... on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism. (2020). European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism. Osteoporosis International, 31 (8), 1461-1470. doi:10.1007/s00198-020-05362-8 Peer Reviewed verified by ORBi |
VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Comparison of two automated assays for the determination of cobalaminin serum [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019. |
VRANKEN, L., FONTAINE, C., VALDES SOCIN, H. G., LUKAS, P., LE GOFF, C., Huyghebaert, L., & CAVALIER, E. (15 November 2019). Impact of Metformin on vitamin B12 status [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019. |
VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Unexpected high levels of Cobalamin (Vitamin B12). Is PEG treatment useful? [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019. |
CASTIGLIONE, V., Pottel, H., Lieske, J. C., LUKAS, P., CAVALIER, E., DELANAYE, P., & Rule, A. (2019). Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones. Journal of Nephrology. doi:10.1007/s40620-019-00623-0 Peer Reviewed verified by ORBi |
GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Phleum pratense may be taken as a marker allergen for Gx3 grass mix. Allergy, 74 (106), 101-331. Peer Reviewed verified by ORBi |
GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Betula verrucosa may be taken as a marker allergen for Tx5 tree mix. Allergy, 74 (106), 130-331. Peer Reviewed verified by ORBi |
Bouchard-Lovighi, G., Veillet, A., Tsoumperi, D., Pages, J., Favre, C., Brossault, L., Dromenq, L., Tessonneau, M., Mougin, B., Priolo, G., Martinasso, G., Mengozzi, G., LUKAS, P., & CAVALIER, E. (June 2019). VIDAS PTH(1-84) ASSAY: Reference limits and comparison with three other third generation PTH assays. Clinica Chimica Acta, 493 (Supplement 1), 331. Peer Reviewed verified by ORBi |
LE GOFF, C., BECKERS, P., LUKAS, P., NIX, C., PEETERS, S., & CAVALIER, E. (21 May 2019). The new Diasorin Androstenedione immunoassay: analytical performances,comparison with a LC-MS/MS and establishment of the reference range values [Poster presentation]. Euromedlab, Barcelone, Spain. |
VRANKEN, L., FONTAINE, C., LUKAS, P., LE GOFF, C., Huyghebaert, L., CAVALIER, E., & VALDES SOCIN, H. G. (May 2019). Evaluation of Metformin impact on vitamin B12 status [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019, Barcelone, Spain. |
VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (May 2019). Comparison of two automated assays for the determination of cobalamin in serum. Which one to choose? [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019. |
VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (May 2019). Unexpected high levels of Cobalamin(Vitamin B12). Is PEG treatment a solution? [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019. |
Le Goff, C., LUKAS, P., NIX, C., GENDEBIEN, A.-S., Fabregat Cabello, N., Peeters, S., & Cavalier, E. (2019). 17-hydroxyprogesterone : validation of a LC-MS/MS method and comparison with the new immunoassay IDS-iSYS 17-OH Progesterone [Poster presentation]. Euromedlab 2019. Peer reviewed |
Castiglione, V., DELANAYE, P., LUKAS, P., & CAVALIER, E. (19 October 2018). Matrix-Gla-Protein: un nouveau marqueur de lithiase urinaire? [Paper presentation]. 23e Confrontations Clinico-Biologiques sur la Lithiase Urinaire, Paris, France. |
Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & NIKKELS, A. (2017). Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D. Archives of Osteoporosis. doi:10.1007/s11657-017-0361-0 Peer Reviewed verified by ORBi |
Courtois, J., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (26 April 2017). Allergie au froment : caractérisation de nouveaux allergènes par immunoblot 2D et spectrométrie de masse [Poster presentation]. Congrès Francophone d'Allergologie, Paris, France. doi:10.1016/j.reval.2017.02.052 |
Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566 Peer Reviewed verified by ORBi |
Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., CAVALIER, E., Reginster, J.-Y., & NIKKELS, A. (March 2017). Effect of body surface, body site and sunscreen application on production of Vitamin D and 25-hydroxyvitamin D after a single narrowband UVB exposure. Osteoporosis International, 28 Suppl 1, 143-144. Peer Reviewed verified by ORBi |
Libon, F., COURTOIS, J., Le Goff, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & Nikkels, A. (2017). Effect of Body Site and Surface on Vitamin D and 25-Hydroxyvitamin D Production after a Single Narrowband UVB Exposure. Journal of Investigative Dermatology, 137 (6), 1391-1393. doi:10.1016/j.jid.2017.01.032 Peer Reviewed verified by ORBi |
Courtois, J., GADISSEUR, R., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., & Quinting, B. (15 October 2016). Hunting for new wheat allergens : a 2D Immunoblot and mass spectrometry approach [Poster presentation]. 4th Food Allergy and Anaphylaxis meeting, Rome, Italy. |
CAVALIER, E., LUKAS, P., BEKAERT, A.-C., PEETERS, S., LE GOFF, C., Yayo, E., DELANAYE, P., & Souberbielle, J.-C. (2016). Analytical and clinical evaluation of the new Fujirebio Lumipulse G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2015-0923 Peer Reviewed verified by ORBi |
Libon, F., Courtois, J., Le Goff, C., LUKAS, P., Seidel, L., Cavalier, E., & Nikkels, A. (October 2015). Effect of body surface area and sunscreen application on production of vitamin D after a single UVB-exposure [Poster presentation]. European Academy of Dermatology and Venerology (EADV), Copenhague, Denmark. |
Libon, F., Courtois, J., LUKAS, P., LE GOFF, C., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (October 2015). Effect of body surface, body site and sunscreen application on production of vitamin D and 25-hydroxyvitamin D after a single narrowband-UVB exposure [Paper presentation]. EADV Congress, Cophenhague, Denmark. |
ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., LUKAS, P., CARLISI, I., LE GOFF, C., GADISSEUR, R., & CAVALIER, E. (August 2015). Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects. Burns: Journal of the International Society for Burn Injuries, 41 (5), 1028-1034. doi:10.1016/j.burns.2014.11.011 Peer Reviewed verified by ORBi |
DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 53 (8), 191-193. doi:10.1515/cclm-2015-0073 Peer Reviewed verified by ORBi |
CAVALIER, E., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., & DELANAYE, P. (October 2014). Les résultats des formules de calcul de la 25(OH)-vitamine D libre varient en fonction des méthodes de dosage de la 25(OH)D [Poster presentation]. 16ème Réunion commune - Société de néphrologie - Société de dialyse, Saint-Etienne, France. |
CAVALIER, E., DUBOIS, B., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., KRZESINSKI, J.-M., & DELANAYE, P. (October 2014). La membrane de dialyse peut-elle avoir une influence sur le statut en vitamine D du patient? [Poster presentation]. 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France. |
CAVALIER, E., DELANAYE, P., LUKAS, P., CARLISI, I., GADISSEUR, R., & Souberbielle, J.-C. (01 August 2014). Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations. Clinical Chemistry and Laboratory Medicine, 52 (8), 1137-41. doi:10.1515/cclm-2013-1027 Peer Reviewed verified by ORBi |
CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (20 April 2014). Evaluation of automated immunoassays for 25 (OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clinica Chimica Acta, 431, 60-5. doi:10.1016/j.cca.2014.01.026 Peer Reviewed verified by ORBi |
CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (April 2014). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the re-standardization of six different 25(OH) vitamin D immunoassays [Poster presentation]. WCO-IOF-ESCEO Seville 2014 : World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases, Séville, Spain. |
ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., CARLISI, I., LUKAS, P., GADISSEUR, R., & CAVALIER, E. (2014). Vitamin D status during acute phase of burn injury : is 25(OH)D measurement an accurate marker ? Nutrients, 6, 2770. Peer Reviewed verified by ORBi |
DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Impact of the stopping of vitamin K antagonist treatment on concentrations of Dephosphorylated and uncarboxylated Matrix Gla protein [Poster presentation]. ASN Kidney Week, Philadelphia, United States - Pennsylvania. |
CAVALIER, E., LUKAS, P., CARLISI, I., GADISSEUR, R., & DELANAYE, P. (October 2013). Aminoterminal propeptide of type I procollagen (P1NP) in chronic kidney disease patients: the assay matters [letter to the editor]. Clinica Chimica Acta, 425, 117-118. Peer Reviewed verified by ORBi |
GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Analytical performance of the IDS-iSYS N-Mid osteocalcin immunoassay [Poster presentation]. AACC Annual meeting 2013, Houston, United States. |
CAVALIER, E., LUKAS, P., CARLISI, I., & Souberbielle, J.-C. (July 2013). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the restandarization of six different 25 (OH) vitamin D immunoassays [Poster presentation]. AACC Annual meeting 2013, Houston, United States. |
GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Performance of the IDS-iSYS 1,25-dihydroxy vitamin D assay [Poster presentation]. AACC Annual meeting, Houston, United States. |
GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (May 2013). Evaluation of the performance of the new automated IDS-ISYS 1,25-dihydroxy vitamin D assay. Biochimica Clinica, 37 (SS), 498. Peer reviewed |
CAVALIER, E., GADISSEUR, R., LUKAS, P., CARLISI, I., & DELANAYE, P. (May 2013). Association of the circulating inactive form of matrix GLA protein (DP-UCMGP) levels and abdominal aortic calcification score (AACS) in haemodialysis patients. Biochimica Clinica, 37 (SS), 215. Peer reviewed |
CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498. Peer reviewed |
LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in healthy subjects. Osteoporosis International, 24 (S1), 279. Peer Reviewed verified by ORBi |
LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on phosphocalcic metabolism biomarkers in healthy adults subjects. Osteoporosis International, 24 (S1), 282. Peer Reviewed verified by ORBi |
LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on bone biomarkers in healthy dults subjects. Osteoporosis International, 24 (S1), 329. Peer Reviewed verified by ORBi |
LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., Souberbielle, J.-C., & CAVALIER, E. (November 2012). Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clinical Chemistry and Laboratory Medicine, 50 (11), 2031-2. doi:10.1515/cclm-2012-0164 Peer Reviewed verified by ORBi |
LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500 [Poster presentation]. AACC 2012, Los Angeles, United States. |
LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native Samples [Poster presentation]. AACC 2012, Los Angeles, United States. |
FORTUNATO, A., LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., ROUSSELLE, O., FERRANTE, N., & CAVALIER, E. (May 2012). Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA Centaur Total Vitamin D [Poster presentation]. The joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinoly, Florence, Italy. |